'We're pretty prolific': Lilly Catalyze360 looks to connect with emerging biotechs across 'all areas'

As Eli Lilly continues to capitalize on its trove of Mounjaro and Zepbound cash with major outside deals, the company’s early external innovation and collaboration arm, Lilly Catalyze360, is welcoming all comers into the fold.